bf/NASDAQ:INO_icon.jpeg

COM:INOVIO

INOVIO Pharmaceuticals

  • Stock

USD

Last Close

4.06

22/11 21:00

Market Cap

240.45M

Beta: -

Volume Today

292.77K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
13.47M
-
10.46M
22.35%
40.57M
288.00%
35.37M
12.83%
42.22M
19.37%
30.48M
27.80%
4.11M
86.51%
7.41M
80.24%
1.77M
76.05%
10.26M
478.23%
832.01K
91.89%
cost of revenue
3.50M
-
gross profit
13.47M
-
10.46M
22.35%
40.57M
288.00%
35.37M
12.83%
42.22M
19.37%
30.48M
27.80%
4.11M
86.51%
7.41M
80.24%
1.77M
76.05%
10.26M
478.23%
-2.67M
126.03%
selling and marketing expenses
-3.50M
-
general and administrative expenses
13.64M
-
15.86M
16.23%
18.06M
13.91%
23.89M
32.27%
28.29M
18.41%
29.32M
3.62%
27.20M
7.20%
37.25M
36.92%
53.75M
44.31%
90.19M
67.78%
47.58M
47.24%
selling general and administrative expenses
13.64M
-
15.86M
16.23%
18.06M
13.91%
23.89M
32.27%
28.29M
18.41%
29.32M
3.62%
27.20M
7.20%
37.25M
36.92%
53.75M
44.31%
90.19M
67.78%
44.08M
51.12%
research and development expenses
21.37M
-
34.10M
59.56%
57.79M
69.50%
88.71M
53.50%
98.57M
11.12%
95.26M
3.36%
88.02M
7.60%
94.25M
7.08%
249.24M
164.46%
187.65M
24.71%
88.48M
52.85%
other expenses
-45.63M
-
348.14K
100.76%
177.56K
49.00%
127.55K
28.16%
806.82K
532.53%
360.80K
55.28%
496.20K
37.53%
3.42M
588.47%
343.37K
89.95%
-3.86M
1,224.61%
-4.71M
22.01%
cost and expenses
35.01M
-
49.95M
42.67%
75.86M
51.86%
112.60M
48.45%
126.86M
12.66%
124.57M
1.81%
115.22M
7.51%
131.49M
14.12%
302.99M
130.42%
277.84M
8.30%
136.06M
51.03%
operating expenses
35.01M
-
49.95M
42.67%
75.86M
51.86%
112.60M
48.45%
126.86M
12.66%
124.57M
1.81%
115.22M
7.51%
131.49M
14.12%
302.99M
130.42%
277.84M
8.30%
132.56M
52.29%
interest expense
88.17M
-
-3.36M
103.81%
-5.18M
54.24%
-2.50M
51.78%
4.56M
282.84%
346.09K
92.42%
7.95M
2,196.69%
8.70M
9.48%
1.94M
77.75%
1.25M
35.24%
1.22M
2.49%
ebitda
24.19M
-
-38.27M
258.24%
-34.54M
9.75%
-75.28M
117.93%
-82.98M
10.23%
-89.46M
7.80%
-105.58M
18.03%
-76.17M
27.86%
-293.33M
285.11%
-268.55M
8.45%
-131.72M
50.95%
operating income
-19.54M
-
-39.50M
102.08%
-34.28M
13.20%
-76.24M
122.37%
-83.64M
9.72%
-94.09M
12.49%
-111.11M
18.09%
-124.08M
11.68%
-301.22M
142.76%
-267.57M
11.17%
-135.23M
49.46%
depreciation and amortization
2.10M
-
1.57M
25.25%
1.92M
22.26%
3.09M
60.84%
3.47M
12.41%
5.00M
44.04%
5.53M
10.63%
47.91M
766.71%
7.88M
83.55%
-979.21K
112.42%
3.50M
457.79%
total other income expenses net
-44.67M
-
3.02M
106.77%
3.78M
24.92%
2.24M
40.75%
-5.18M
331.24%
-1.63M
68.55%
-9.70M
495.94%
-38.81M
300.06%
-2.01M
94.83%
-10.08M
402.36%
109.31K
101.08%
income before tax
-66.08M
-
-36.14M
45.31%
-31.20M
13.67%
-73.74M
136.34%
-88.21M
19.62%
-94.80M
7.47%
-120.81M
27.44%
-162.89M
34.83%
-303.22M
86.15%
-277.65M
8.43%
-135.12M
51.34%
income tax expense
88.12M
-
-3.72M
104.22%
-2.10M
43.64%
-4.62M
120.38%
1.76M
137.98%
2.17M
23.56%
-257.33K
111.86%
52.20M
20,383.34%
2.16M
95.86%
10.01M
363.35%
2
100.00%
net income
-66.03M
-
-36.12M
45.29%
-29.19M
19.20%
-73.74M
152.64%
-88.21M
19.62%
-96.97M
9.93%
-120.55M
24.32%
-215.09M
78.42%
-305.38M
41.98%
-287.66M
5.80%
-135.12M
53.03%
weighted average shs out
46.09M
-
59.13M
28.29%
68.20M
15.34%
73.21M
7.36%
81.78M
11.70%
92.54M
13.16%
98.72M
6.68%
155.13M
57.14%
208.83M
34.62%
238.62M
14.27%
22.17M
90.71%
weighted average shs out dil
46.09M
-
59.41M
28.90%
68.37M
15.08%
73.21M
7.09%
81.92M
11.89%
92.54M
12.97%
98.72M
6.68%
155.13M
57.14%
208.83M
34.62%
238.62M
14.27%
22.17M
90.71%
eps
-1.43
-
-0.61
57.34%
-0.43
29.51%
-1.01
134.88%
-1.08
6.93%
-1.05
2.78%
-1.22
16.19%
-1.39
13.93%
-1.46
5.04%
-1.21
17.12%
-6.09
403.31%
epsdiluted
-1.43
-
-0.61
57.34%
-0.43
29.51%
-1.01
134.88%
-1.08
6.93%
-1.05
2.78%
-1.22
16.19%
-1.39
13.93%
-1.46
5.04%
-1.21
17.12%
-6.09
403.31%

All numbers in USD (except ratios and percentages)